Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen, SimulConsult Ink Deal for Clinical Interpretation of Genetic Tests

NEW YORK (GenomeWeb News) – Under an agreement announced today, Courtagen Life Sciences will incorporate SimulConsult's Genome-Phenome Analyzer into its process for the clinical interpretation of genetic tests.

The Genome-Phenome Analyzer is software that allows researchers to combine a genome variant table with the phenotypic data entered by a clinician "thereby using the full power of genome [and] phenome to arrive at a diagnosis in seconds," SimulConsult said on its website.

The curated phenome database is combined with a Bayesian inference engine to deliver a differential diagnosis based on clinical findings and laboratory tests, SimulConsult said, adding the bioinformatics genome annotation software has the ability to predict the pathogenicity of variants.

Courtagen President Brendan McKernan said in a statement that integrating the software with Courtagen's ZiPhyr molecular platform "will enhance the quality of the clinical information in our database, provide greater personalization of patient reports, and enable actionable results for medical providers and pharmaceutical companies looking to optimize treatments and therapy options."

Financial and other terms of the deal were not disclosed.